No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 10,764 | 10,507 | 9,571 | 10,232 | 9,644 | 8,689 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 3,245 | -4,462 | 489 | -2,883 | 1,459 | -1,309 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Tech-Bank Food Co., Ltd., along with its affiliated entities, operates extensively within the agricultural and animal husbandry sectors, conducting business both domestically in China and internationally. The company's operations are diversified across five principal divisions: Aquatic Feed, Biological Products, Pig-Breeding, Fresh Food, and Engineering Construction. Its Aquatic Feed segment focuses on producing and distributing feed for a wide variety of aquatic animals, including shrimp, crabs, turtles, frogs, and fish, in addition to supplying environmentally friendly food production materials. The Biological Products division is dedicated to developing and providing specialized animal vaccines, such as the pathogenic PRRS cell suspension culture heat-resistant protective agent live vaccine (JAX1-R Strain) and the avian influenza (H9) cell suspension inactivated vaccine, serving the animal health industry, and also offers livestock and poultry products. Tech-Bank Food's Pig-Breeding operations include the provision of genetic products for pigs. Moreover, its Fresh Food segment delivers a diverse array of gourmet items, such as caviars, hairy crabs, crystal shrimps, and yellow croaker products, complemented by its activities in pork and seafood processing. Finally, the Engineering Construction division offers end-to-end services encompassing the planning, design, construction, and management of various projects. Established in 1996 and headquartered in Shanghai, China, the company underwent a name change in May 2017, transitioning from its former identity as Ningbo Tech-Bank Co., Ltd. to its current designation, Tech-Bank Food Co., Ltd.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Tech-Bank Food Co., Ltd. (002124.SZ)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Tech-Bank Food Co., Ltd., along with its affiliated entities, operates extensively within the agricultural and animal husbandry sectors, conducting business both domestically in China and internationally. The company's operations are diversified across five principal divisions: Aquatic Feed, Biological Products, Pig-Breeding, Fresh Food, and Engineering Construction. Its Aquatic Feed segment focuses on producing and distributing feed for a wide variety of aquatic animals, including shrimp, crabs, turtles, frogs, and fish, in addition to supplying environmentally friendly food production materials. The Biological Products division is dedicated to developing and providing specialized animal vaccines, such as the pathogenic PRRS cell suspension culture heat-resistant protective agent live vaccine (JAX1-R Strain) and the avian influenza (H9) cell suspension inactivated vaccine, serving the animal health industry, and also offers livestock and poultry products. Tech-Bank Food's Pig-Breeding operations include the provision of genetic products for pigs. Moreover, its Fresh Food segment delivers a diverse array of gourmet items, such as caviars, hairy crabs, crystal shrimps, and yellow croaker products, complemented by its activities in pork and seafood processing. Finally, the Engineering Construction division offers end-to-end services encompassing the planning, design, construction, and management of various projects. Established in 1996 and headquartered in Shanghai, China, the company underwent a name change in May 2017, transitioning from its former identity as Ningbo Tech-Bank Co., Ltd. to its current designation, Tech-Bank Food Co., Ltd.